Modified DSM-5 opioid use disorder criteria for pain patients
Two years ago, I asked, “Doctors diagnosing addiction: Are the blind leading the blind?”
The estimated rates of substance use disorder among clinical patients treated for pain vary greatly, depending on whom one believes. Studies also suffer from a widespread failure to address genetically mediated variability in minimum effective opioid dose between individuals. Thus, I have many times respectfully suggested that the entire body of literature on opioid …
Modified DSM-5 opioid use disorder criteria for pain patients











![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)








![Safety-net dentistry restores human dignity for patients recovering from severe addiction [PODCAST]](https://kevinmd.com/wp-content/uploads/b3db3337-cf69-4a9b-ad93-f5c4c5d8d499-190x100.jpeg)